This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

In the intervention group, the goal is to initiate bowel motility by mobilizing women early in the post-cesarean period. This increased bowel motility will facilitate gas expulsion, thus minimizing pain levels. Caffeine consumption will help keep pain levels at a minimum. By minimizing pain, women will experience positive psychological well-being.

Inclusion Criteria:

1. Being between 18 and 35 years of age,
2. Women who underwent cesarean delivery under spinal anesthesia,
3. Having a post-cesarean pain level of 4 or higher,
4. Being able to understand and write Turkish and communicate effectively with researchers.

Exclusion Criteria:

1. Women who underwent emergency cesarean delivery,
2. Those with pregnancy complications (preeclampsia, placenta previa, etc.),
3. Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis),
4. Those with sensitivity or allergy to caffeine,
5. Those with a history of chronic pain syndrome or dependence on analgesics,
6. Regular coffee drinkers (≥2 cups per day),
7. Intraoperative complications such as bowel or bladder injury,

i) Those who cannot comply with the study protocol or complete the follow-up process.

Removal Criteria:

1. Participants are excluded from the study under the following conditions:
2. During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding),
3. Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn,
4. Development of severe postoperative nausea, vomiting, or intolerance to oral intake,
5. Inability to consume or refusal to consume coffee according to the study protocol,
6. Withdrawal of consent by the participant at any point during the study,
7. Failure to comply with surgical procedures or loss of follow-up,
8. Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).

Women aged 18-35